Published in J Biol Chem on February 19, 1999
Regulatory divergence modifies limb length between mammals. Genes Dev (2008) 1.96
Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region. Mol Cell Biol (1999) 1.03
Bright/ARID3A contributes to chromatin accessibility of the immunoglobulin heavy chain enhancer. Mol Cancer (2007) 0.99
The epigenetic stability of the locus control region-deficient IgH locus in mouse hybridoma cells is a clonally varying, heritable feature. Genetics (2004) 0.88
Complex regulation of somatic hypermutation by cis-acting sequences in the endogenous IgH gene in hybridoma cells. Proc Natl Acad Sci U S A (2005) 0.87
Evolution of transcriptional enhancers in the immunoglobulin heavy-chain gene: functional characteristics of the zebrafish Emu3' enhancer. Immunogenetics (2005) 0.82
Modeling disease risk through analysis of physical interactions between genetic variants within chromatin regulatory circuitry. Nat Genet (2016) 0.77
A weakened transcriptional enhancer yields variegated gene expression. PLoS One (2006) 0.76
Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene. Nat Genet (1993) 3.11
The coding function of nucleotide sequences can be discerned by statistical analysis. J Theor Biol (1981) 2.61
Mutant immunoglobulin genes have repetitive DNA elements inserted into their intervening sequences. Proc Natl Acad Sci U S A (1982) 2.44
Deletions in immunoglobulin mu chains. EMBO J (1982) 2.35
Production of functional chimaeric mouse/human antibody. Nature (1985) 2.35
Functional immunoglobulin M production after transfection of cloned immunoglobulin heavy and light chain genes into lymphoid cells. Proc Natl Acad Sci U S A (1983) 2.03
Properties of recombination-deficient mutants of bacteriophage lambda. J Mol Biol (1970) 1.80
Homologous recombination can restore normal immunoglobulin production in a mutant hybridoma cell line. Proc Natl Acad Sci U S A (1988) 1.70
Mutations affecting the structure and function of immunoglobulin M. Mol Cell Biol (1982) 1.58
Immunoglobulin production by lymphocyte hybridomas. Eur J Immunol (1978) 1.56
Transposition of two different intracisternal A particle elements into an immunoglobulin kappa-chain gene. Mol Cell Biol (1984) 1.55
Gene replacement with one-sided homologous recombination. Mol Cell Biol (1992) 1.51
Transfer of a cloned immunoglobulin light-chain gene to mutant hybridoma cells restores specific antibody production. Nature (1983) 1.51
Isolation, structure and expression of mammalian genes for histidyl-tRNA synthetase. Nucleic Acids Res (1987) 1.40
IgM--molecular requirements for its assembly and function. Immunol Today (1989) 1.38
New att mutants of phage lambda. Virology (1976) 1.20
On the linkage between RNA processing and RNA translatability. J Biol Chem (1994) 1.14
B and T cells are not required for the viable motheaten phenotype. J Exp Med (1996) 1.14
On the structure of polymeric IgM. Eur J Immunol (1988) 1.11
Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med (1988) 1.08
Intermolecular disulfide bonding in IgM: effects of replacing cysteine residues in the mu heavy chain. EMBO J (1989) 1.07
Analysis of hybridoma mutants defective in synthesis of immunoglobulin M. Somat Cell Mol Genet (1986) 1.06
Mouse NKR-P1B, a novel NK1.1 antigen with inhibitory function. J Immunol (1999) 1.05
Nucleotide sequences of immunoglobulin mu heavy chain deletion mutants. Nucleic Acids Res (1983) 1.03
Variegated expression of the endogenous immunoglobulin heavy-chain gene in the absence of the intronic locus control region. Mol Cell Biol (1999) 1.03
Cellular and molecular restrictions of the lymphocyte fusion. Curr Top Microbiol Immunol (1978) 1.02
A hit-and-run system for introducing mutations into the Ig H chain locus of hybridoma cells by homologous recombination. J Immunol (1993) 1.02
Homologous recombination between transferred and chromosomal immunoglobulin kappa genes. Mol Cell Biol (1988) 1.01
Immunoglobulin mu and gamma heavy chain classes are not determined by class-specific RNA-splicing enzymes. Nature (1978) 1.00
Expression of the (recombinant) endogenous immunoglobulin heavy-chain locus requires the intronic matrix attachment regions. Mol Cell Biol (1997) 0.99
Model for wandering restriction enzymes. Nature (1974) 0.97
Infrequent translation of a nonsense codon is sufficient to decrease mRNA level. Mol Biol Cell (1999) 0.96
Domain-switched mouse IgM/IgG2b hybrids indicate individual roles for C mu 2, C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q. J Immunol (1997) 0.95
Amplification of the gene for histidyl-tRNA synthetase in histidinol-resistant Chinese hamster ovary cells. Mol Cell Biol (1985) 0.95
Activation of complement by immunoglobulin M is impaired by the substitution serine-406----asparagine in the immunoglobulin mu heavy chain. Proc Natl Acad Sci U S A (1986) 0.95
Assembly of IgM. Role of disulfide bonding and noncovalent interactions. J Immunol (1995) 0.93
Complement activation by IgM: evidence for the importance of the third constant domain of the mu heavy chain. Eur J Immunol (1987) 0.92
C1 binding by mouse IgM. The effect of abnormal glycosylation at position 402 resulting from a serine to asparagine exchange at residue 406 of the mu-chain. J Biol Chem (1990) 0.92
Epitope mapping of the cloned human autoantigen, histidyl-tRNA synthetase. Analysis of the myositis-associated anti-Jo-1 autoimmune response. J Immunol (1989) 0.91
Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J (1995) 0.91
Effects of vector cutting on its recombination with the chromosomal immunoglobulin gene in hybridoma cells. Somat Cell Mol Genet (1991) 0.89
C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain. J Biol Chem (1988) 0.88
Overexpression of the protein tyrosine phosphatase, nonreceptor type 6 (PTPN6), in human epithelial ovarian cancer. Gynecol Oncol (1995) 0.88
Production of mouse V/human C chimeric kappa genes by homologous recombination in hybridoma cells. Analysis of vector design and recombinant gene expression. J Immunol (1994) 0.88
Differential glycosylation of polymeric and monomeric IgM. Mol Immunol (1989) 0.87
Effects of mutation position on frequency of marker rescue by homologous recombination. Mol Cell Biol (1992) 0.87
Analysis of a hot spot for DNA insertion suggests a mechanism for Ig switch recombination. J Immunol (1996) 0.86
An improved system of somatic cell molecular genetics for analyzing the requirements of Ig synthesis and function. Int Immunol (1994) 0.86
A region of the immunoglobulin-mu heavy chain necessary for forming pentameric IgM. J Immunol (1986) 0.85
Isolation of new nonsense and frameshift mutants in the immunoglobulin mu heavy-chain gene of hybridoma cells. Somat Cell Mol Genet (1993) 0.85
An element in the endogenous IgH locus stimulates gene targeting in hybridoma cells. Nucleic Acids Res (1996) 0.84
A V region mutation in a phosphocholine-binding monoclonal antibody results in loss of antigen binding. J Immunol (1991) 0.84
Interplay of J chain and disulfide bonding in assembly of polymeric IgM. Int Immunol (1997) 0.84
Mapping of amino acid residues in the C mu 3 domain of mouse IgM important in macromolecular assembly and complement-dependent cytolysis. J Immunol (1994) 0.84
Structural and functional analysis of J chain-deficient IgM. J Immunol (1998) 0.84
The Ig heavy chain switch region is a hotspot for insertion of transfected DNA. J Immunol (1995) 0.84
Treatment of rheumatoid arthritis with a DR4/1 peptide. J Rheumatol (2000) 0.83
Mutations of the mouse mu H chain which prevent polymer assembly. J Immunol (1989) 0.83
Analysis of IgM structures involved in J chain incorporation. J Immunol (1997) 0.83
Targeted removal of the mu switch region from mouse hybridoma cells. A test of its role in gene expression in the endogenous IgH locus. J Immunol (1995) 0.83
Biochemical genetics of the mouse IgM system. Can J Biochem Cell Biol (1984) 0.82
Biological properties of chimeric antibodies. Interaction with complement. Mol Biol Med (1987) 0.82
Substitution of asparagine for serine-406 of the immunoglobulin mu heavy chain alters glycosylation at asparagine-402. Biochem Biophys Res Commun (1991) 0.81
C1q binding properties of monomer and polymer forms of mouse IgM mu-chain variants. Pro544Gly and Pro434Ala. J Immunol (1994) 0.81
Murine SHP-1 splice variants with altered Src homology 2 (SH2) domains. Implications for the SH2-mediated intramolecular regulation of SHP-1. J Biol Chem (1999) 0.81
Cellular localization of the target structures recognized by the anti-Jo-1 antibody: immunofluorescence studies on cultured human myoblasts. J Rheumatol (1991) 0.80
Structural requirements for IgM assembly and cytolytic activity. Effects of mutations in the oligosaccharide acceptor site at Asn402. J Immunol (1989) 0.80
Physical mapping of coliphage lambda att2. Virology (1976) 0.78
Familial monozygotic twinning: an autosomal dominant form of monozygotic twinning with variable penetrance. Prog Clin Biol Res (1978) 0.78
The IgA/IgM receptor expressed on a murine B cell lymphoma is poly-Ig receptor. J Immunol (2000) 0.77
Transposition of intracisternal A-particle genes in mouse hybridomas. J Cell Physiol Suppl (1984) 0.77
Intraluminal crystalloids are highly associated with prostatic adenocarcinoma on concurrent biopsy specimens. Prostate Cancer Prostatic Dis (2007) 0.77
Gene transfer of immunoglobulin light chain restores heavy chain secretion. J Immunol (1986) 0.77
Allelic exclusion model questioned. Nature (1992) 0.75
A practical approach to hypnosis for the general practitioner. N Y State Dent J (1970) 0.75
Molecular characterization of a mutant hybridoma secreting truncated IgM. Immunol Lett (1985) 0.75
Expression of an immunoglobulin kappa light-chain gene in lymphoid cells using a bovine papillomavirus-1 (BPV-1) vector. Gene (1988) 0.75
Impact of training level of urology residents on the detection of prostate cancer on TRUS biopsy. Prostate Cancer Prostatic Dis (2004) 0.75
Transcriptional analyses of the gene region that encodes human histidyl-tRNA synthetase: identification of a novel bidirectional regulatory element. Gene (1993) 0.75
SHP-1 variant proteins are absent in motheaten mice despite presence of splice variant transcripts with open reading frames. Mol Immunol (2000) 0.75
Genetic etiology for monozygotic twinning. Birth Defects Orig Artic Ser (1978) 0.75